Raymond DuBois to Inflammation
This is a "connection" page, showing publications Raymond DuBois has written about Inflammation.
Connection Strength
1.700
-
Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis. 2015 Oct; 36(10):1085-93.
Score: 0.326
-
The Jeremiah Metzger Lecture: Inflammation, Immune Modulators, and Chronic Disease. Trans Am Clin Climatol Assoc. 2015; 126:230-6.
Score: 0.311
-
The role of the PGE2-aromatase pathway in obesity-associated breast inflammation. Cancer Discov. 2012 Apr; 2(4):308-10.
Score: 0.257
-
Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer. Gastroenterol Clin North Am. 2010 Sep; 39(3):697-707.
Score: 0.230
-
Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. Cancer Res. 2005 Oct 01; 65(19):8583-6.
Score: 0.164
-
Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer. Cancer Prev Res (Phila). 2022 06 02; 15(6):355-363.
Score: 0.130
-
Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002; 53:35-57.
Score: 0.126
-
NSAIDs and prostate cancer risk. Cancer J. 2006 Mar-Apr; 12(2):108-9.
Score: 0.042
-
Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J Biol Chem. 2005 Oct 21; 280(42):35562-70.
Score: 0.041
-
Cyclooxygenase as a target in lung cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 2):4266s-4269s.
Score: 0.037
-
Leukotriene A4 signaling, inflammation, and cancer. J Natl Cancer Inst. 2003 Jul 16; 95(14):1028-9.
Score: 0.035